Medicine and Dentistry
Peritoneum Metastasis
100%
Rectum Cancer
83%
Systemic Therapy
66%
Cytoreductive Surgery
65%
Overall Survival
62%
Radiation Therapy
57%
Hyperthermic Intraperitoneal Chemotherapy
54%
Neoplasm
51%
Head and Neck Squamous Cell Carcinoma
50%
Arm
47%
Irinotecan
47%
Malignant Neoplasm
37%
Cancer Diagnosis
37%
Capecitabine
36%
Metastatic Carcinoma
35%
Chemoradiotherapy
33%
Colorectal Liver Metastasis
33%
Neoadjuvant Chemotherapy
33%
Retrospective Study
33%
Oropharynx Carcinoma
33%
Neoadjuvant Therapy
27%
Oxaliplatin
27%
Colorectal Carcinoma
26%
Local Therapy
25%
FOLFOX
25%
Bevacizumab
25%
Distant Metastasis
25%
Liver Metastasis
23%
Intraperitoneal Chemotherapy
23%
Recurrence Risk
20%
Patient-Reported Outcome
20%
Cohort Analysis
20%
Chemoradiation Therapy
18%
Lung Metastasis
18%
Cancer Therapy
18%
Cancer Prognosis
18%
Fluorouracil
17%
Folinic Acid
17%
Metastatic Colorectal Cancer
16%
Diarrhea
16%
Head and Neck Cancer
16%
Immunosuppressive Treatment
16%
Transanal Endoscopic Microsurgery
16%
Surgical Margin
16%
COVID-19
16%
Bone Necrosis
16%
Ulcer
16%
Systematic Review
16%
Clinical Trial
16%
Nivolumab
16%
Pharmacology, Toxicology and Pharmaceutical Science
Irinotecan
80%
Chemotherapy
77%
Rectum Cancer
66%
Peritoneum Metastasis
66%
Intraperitoneal Chemotherapy
55%
Chemoradiation Therapy
50%
Capecitabine
47%
Pharmacokinetics
47%
Head and Neck Cancer
35%
Cisplatin
33%
Squamous Cell Carcinoma
33%
Overall Survival
31%
Neoplasm
29%
Progression Free Survival
27%
Cohort Study
25%
Cetuximab
23%
Malignant Neoplasm
23%
Diarrhea
22%
Bevacizumab
21%
Lung Metastasis
21%
Distant Metastasis
21%
Oxaliplatin
19%
Methotrexate
19%
Drug Interaction
18%
Solid Malignant Neoplasm
16%
Duragesic
16%
Pharmacogenetics
16%
Lung Nodule
16%
Trifluridine
16%
Tipiracil
16%
Omeprazole
16%
Phase II Trials
16%
Drug-Drug Interaction
16%
Metastatic Colorectal Cancer
16%
Nivolumab
16%
Retrospective Study
16%
Head and Neck Squamous Cell Carcinoma
16%
Antineoplastic Agent
16%
Colorectal Carcinoma
15%
Diseases
15%
Survival Rate
14%
Peritoneum Cancer
13%
Docetaxel
11%
Fluorouracil
11%
Folinic Acid
11%
Loss of Appetite
11%
Maximum Tolerated Dose
10%
Treatment Group
10%
Peritoneal Disease
8%
ABCG2
8%